pharmaphorum Top Stories - 16 December 2024

pharmaphorum Top Stories - 16 December 2024

In this week’s top stories, Luigi Mangione, 26, has been charged with the murder of UnitedHealth CEO Brian Thompson, providing new developments in the case.

Elsewhere, a new study highlights the alarming rise of colorectal cancer in younger age groups, prompting concerns and calls for further research, and the American Society of Hematology has revealed a study exposing the disparities in access to stem cell transplants based on US zip codes, emphasizing the need for equitable healthcare.

Plus, AstraZeneca and MSD's Lynparza has shown significant long-term survival benefits for early breast cancer patients, marking a milestone in cancer treatment.

Finally, Ken Mulvany has returned to BenevolentAI, initiating a major strategic overhaul to refocus the company on its core strengths in AI-driven drug discovery.

All this and more on pharmaphorum.com.

Top Stories

Suspect in UnitedHealth CEO killing charged with murder

26-year-old Luigi Mangione has been charged with murder and other offences following the murder of UnitedHealth Group CEO Brian Thompson last week.

Why is colorectal cancer rising in younger age groups?

A study has confirmed that colorectal cancer is rising in younger adults around the world, with England among countries seeing the fastest rise.

ASH: Stem cell transplant study exposes US zip-code lottery

Access to a stem cell transplant in the US - and the chances of surviving it - depends on social and economic factors, finds a new study.

Lynparza boosts long-term survival in early breast cancer

A single year of adjuvant treatment with 阿斯利康 and MSD's PARP inhibitor Lynparza is still providing a survival benefit six years later.

Mulvany hits the reset button at BenevolentAI

The shape of BenevolentAI following the return of co-founder Ken Mulvany has started to crystallise and could see the company return to private hands.

READ MORE NEWS

要查看或添加评论,请登录

pharmaphorum的更多文章

社区洞察

其他会员也浏览了